{"id":60882,"date":"2024-02-28T07:13:05","date_gmt":"2024-02-28T07:13:05","guid":{"rendered":"https:\/\/medsname.com\/dytor\/"},"modified":"2026-05-01T10:49:16","modified_gmt":"2026-05-01T10:49:16","slug":"dytor","status":"publish","type":"product","link":"https:\/\/medsbase.com\/cs\/product\/dytor\/","title":{"rendered":"Dytor"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 24px 0;border-radius:4px;\">\n<h3 class=\"wp-block-heading\" style=\"margin:0 0 8px 0;font-size:16px;font-weight:700;\">\u26a1 Rychl\u00e1 odpov\u011b\u010f \u2014 Co je Dytor?<\/h3>\n<p style=\"margin:0;\"><strong>Dytor<\/strong> je <strong>5 \/ 10 \/ 20 mg tableta torasemidu<\/strong> od Cipla \u2014 a <strong>kli\u010dkov\u00e9 diuretikum (pyridin-sulfonylmo\u010dovinov\u00e1 struktura)<\/strong> kter\u00fd p\u016fsob\u00ed na <strong>NKCC2 (Na-K-2Cl kotransport\u00e9r) v tlust\u00e9 \u010d\u00e1sti vzestupn\u00e9ho ram\u00e9nka<\/strong>. Torasemid (v americk\u00e9 nomenklatu\u0159e torsemid) byl uveden na trh spole\u010dnost\u00ed Boehringer Mannheim v roce 1993 \u2014 t\u0159et\u00ed v\u00fdznamn\u00e9 kli\u010dkov\u00e9 diuretikum po furosemidu a bumetanidu. Uv\u00e1d\u011bn na trh pro svou p\u0159edv\u00eddatelnou biologickou dostupnost a del\u0161\u00ed \u00fa\u010dinek ve srovn\u00e1n\u00ed s furosemidem. Polo\u010das 3-4 hodiny (del\u0161\u00ed ne\u017e furosemid); n\u00e1stup \u00fa\u010dinku 30-60 minut; vrchol \u00fa\u010dinku 1-2 hodiny; d\u00e9lka \u00fa\u010dinku 6-8 hodin. Hlavn\u00ed indikace: <strong>chronick\u00fd ed\u00e9m p\u0159i srde\u010dn\u00edm selh\u00e1n\u00ed, hypertenze (v\u010detn\u011b rezistentn\u00ed), jatern\u00ed ascites, ed\u00e9m u chronick\u00e9ho onemocn\u011bn\u00ed ledvin<\/strong>. Typick\u00e9 d\u00e1vkov\u00e1n\u00ed: <strong>Hypertenze:<\/strong> 5-10 mg jednou denn\u011b r\u00e1no. Torasemid je <strong>jedin\u00e9 kli\u010dkov\u00e9 diuretikum s rozumn\u00fdmi d\u016fkazy pro antihypertenzn\u00ed \u00fa\u010dinek<\/strong> \u2014 jeho del\u0161\u00ed \u00fa\u010dinek a dodate\u010dn\u00e1 anti-aldosteronov\u00e1\/anti-fibrotick\u00e1 aktivita jej \u010din\u00ed vhodn\u011bj\u0161\u00edm pro jednodenn\u00ed kontrolu krevn\u00edho tlaku ne\u017e furosemid. Kl\u00ed\u010dov\u00e9 kontraindikace: viz \u00fapln\u00fd seznam n\u00ed\u017ee. Sledujte elektrolyty, kreatinin a gluk\u00f3zu. <strong>Nekombinujte s lithiem<\/strong> (thiazidov\u00e1\/smy\u010dkov\u00e1 diuretika mohou vyvolat toxicitu lithia). <strong>U\u017eit\u00ed v t\u011bhotenstv\u00ed je p\u0159\u00edpad od p\u0159\u00edpadu<\/strong> (viz pozn\u00e1mka k t\u011bhotenstv\u00ed). U v\u011bt\u0161iny hypertonik\u016f funguj\u00ed diuretika nejl\u00e9pe jako <strong>druh\u00fd nebo t\u0159et\u00ed l\u00e9k<\/strong> \u2014 obvykle v kombinaci s ARB, ACE inhibitorem nebo blok\u00e1torem kalciov\u00fdch kan\u00e1l\u016f sp\u00ed\u0161e ne\u017e samostatn\u011b.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Co z\u00edsk\u00e1te s MedsBase:<\/strong> V\u00fdrobce certifikovan\u00fd WHO-GMP \u00b7 Diskr\u00e9tn\u00ed balen\u00ed \u00b7 Celosv\u011btov\u00e1 doprava \u00b7 V\u00edce ne\u017e 1 400 ov\u011b\u0159en\u00fdch <a href=\"https:\/\/medsbase.com\/cs\/reviews\/\">recenz\u00ed z\u00e1kazn\u00edk\u016f<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed <a href=\"https:\/\/medsbase.com\/cs\/medsbase-re-shipment-assurance-policy\/\"><strong>Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n<h3>Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n<p>Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n<h2 class=\"wp-block-heading\">Co je Dytor?<\/h2>\n<p>Dytor je peror\u00e1ln\u00ed tableta torasemidu v d\u00e1vk\u00e1ch 5\/10\/20 mg od spole\u010dnosti Cipla, dod\u00e1van\u00e1 v balen\u00ed po 30-180 tablet\u00e1ch. Torasemid (v americk\u00e9 nomenklatu\u0159e torsemid) byl uveden na trh spole\u010dnost\u00ed Boehringer Mannheim v roce 1993 \u2013 jde o t\u0159et\u00ed v\u00fdznamn\u00fd kli\u010dkov\u00fd diuretikum po furosemidu a bumetanidu. Na trhu je prosazov\u00e1n d\u00edky sv\u00e9 p\u0159edv\u00eddateln\u00e9 biologick\u00e9 dostupnosti a del\u0161\u00edmu trv\u00e1n\u00ed \u00fa\u010dinku ve srovn\u00e1n\u00ed s furosemidem.<\/p>\n<h2 class=\"wp-block-heading\">Jak torasemid funguje<\/h2>\n<p>Torasemid inhibuje <strong>NKCC2 (Na-K-2Cl kotransport\u00e9r) v tlust\u00e9 \u010d\u00e1sti vzestupn\u00e9ho ram\u00e9nka<\/strong>. N\u00e1sledn\u00e9 \u00fa\u010dinky:<\/p>\n<ul>\n<li><strong>Dramatick\u00e9 sn\u00ed\u017een\u00ed zp\u011btn\u00e9ho vst\u0159eb\u00e1v\u00e1n\u00ed sod\u00edku<\/strong> \u2014 kli\u010dkov\u00e1 diuretika blokuj\u00ed nejv\u011bt\u0161\u00ed segment nefronu vst\u0159eb\u00e1vaj\u00edc\u00ed sod\u00edk; a\u017e 25% filtrovan\u00e9ho sod\u00edku m\u016f\u017ee b\u00fdt vylou\u010deno<\/li>\n<li><strong>V\u00fdrazn\u00e1 diur\u00e9za<\/strong> do 1-2 hodin po peror\u00e1ln\u00edm pod\u00e1n\u00ed (5 minut IV) \u2014 u\u017eite\u010dn\u00e9 pro akutn\u00ed dekompenzovan\u00e9 srde\u010dn\u00ed selh\u00e1n\u00ed a plicn\u00ed ed\u00e9m<\/li>\n<li><strong>Ztr\u00e1ta ho\u0159\u010d\u00edku a v\u00e1pn\u00edku<\/strong> krom\u011b sod\u00edku a drasl\u00edku \u2014 na rozd\u00edl od thiazid\u016f, kter\u00e9 zadr\u017euj\u00ed v\u00e1pn\u00edk<\/li>\n<li><strong>P\u0159\u00edm\u00e1 venodilatace<\/strong> b\u011bhem minut po IV pod\u00e1n\u00ed \u2014 p\u0159isp\u00edv\u00e1 k \u00falev\u011b od p\u0159\u00edznak\u016f u akutn\u00edho plicn\u00edho ed\u00e9mu je\u0161t\u011b p\u0159ed n\u00e1stupem diur\u00e9zy<\/li>\n<li><strong>Aktivuje synt\u00e9zu prostaglandin\u016f<\/strong> v ledvin\u00e1ch \u2014 z\u00e1klad interakce s NSAID (NSAID oslabuj\u00ed \u00fa\u010dinek kli\u010dkov\u00fdch diuretik)<\/li>\n<li><strong>M\u00edrn\u00e1 antagonizace mineralokortikoidn\u00edch receptor\u016f<\/strong> \u2013 sni\u017euje hypokal\u00e9mii a poskytuje \u010d\u00e1ste\u010dnou antifibrotickou aktivitu na myokardu<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Schv\u00e1len\u00e9 a v\u011bdecky podlo\u017een\u00e9 indikace<\/h2>\n<ul>\n<li><strong>Otoky p\u0159i chronick\u00e9m srde\u010dn\u00edm selh\u00e1n\u00ed, hypertenze (v\u010detn\u011b rezistentn\u00ed), jatern\u00ed ascites, otoky p\u0159i chronick\u00e9m onemocn\u011bn\u00ed ledvin<\/strong> \u2014 prim\u00e1rn\u00ed indikace<\/li>\n<li><strong>Chronick\u00e9 srde\u010dn\u00ed selh\u00e1n\u00ed s otoky<\/strong><\/li>\n<li><strong>Jatern\u00ed ascites<\/strong> (v kombinaci se spironolaktonem)<\/li>\n<li><strong>Hypertenze, v\u010detn\u011b rezistentn\u00ed hypertenze<\/strong> (jedin\u00e9 kli\u010dkov\u00e9 diuretikum s dostate\u010dnou d\u016fkazn\u00ed z\u00e1kladnou pro l\u00e9\u010dbu hypertenze)<\/li>\n<li><strong>Otoky spojen\u00e9 s chronick\u00fdm onemocn\u011bn\u00edm ledvin<\/strong> \u2014 \u00fa\u010dinn\u00fd p\u0159i eGFR &lt;30, kde thiazidy selh\u00e1vaj\u00ed<\/li>\n<li><strong>Nereagov\u00e1n\u00ed na furosemid<\/strong> \u2014 p\u0159echod na torasemid \u010dasto obnovuje \u00fa\u010dinek d\u00edky lep\u0161\u00ed biologick\u00e9 dostupnosti<\/li>\n<\/ul>\n<p><strong>Kl\u00ed\u010dov\u00e9 d\u016fkazy z klinick\u00fdch studi\u00ed:<\/strong> <strong>Studie TORIC (2002)<\/strong> \u2014 observa\u010dn\u00ed studie 1 377 pacient\u016f se srde\u010dn\u00edm selh\u00e1n\u00edm; torasemid vs furosemid, skupina s torasemidem vykazovala o 52 % ni\u017e\u0161\u00ed mortalitu. \u0160iroce citovan\u00e1, ale kritizovan\u00e1 za nerandomizovan\u00fd design. <strong>TRANSFORM-HF (2023)<\/strong> \u2014 rozs\u00e1hl\u00e1 randomizovan\u00e1 studie 2 859 pacient\u016f se srde\u010dn\u00edm selh\u00e1n\u00edm, torasemid vs furosemid; <strong>\u017e\u00e1dn\u00fd v\u00fdznamn\u00fd rozd\u00edl<\/strong> v celkov\u00e9 mortalit\u011b po 12 m\u011bs\u00edc\u00edch. Sou\u010dasn\u00fd z\u00e1v\u011br: torasemid je p\u0159inejmen\u0161\u00edm stejn\u011b dobr\u00fd jako furosemid; volba z\u00e1vis\u00ed na biologick\u00e9 dostupnosti, pohodl\u00ed a sn\u00e1\u0161enlivosti sp\u00ed\u0161e ne\u017e na mortalit\u011b.<\/p>\n<h2 class=\"wp-block-heading\">D\u00e1vkov\u00e1n\u00ed Dytoru<\/h2>\n<p><strong>Chronick\u00e1 d\u00e1vka:<\/strong> <strong>Hypertenze:<\/strong> 5-10 mg jednou denn\u011b r\u00e1no. Torasemid je <strong>jedin\u00e9 kli\u010dkov\u00e9 diuretikum s rozumn\u00fdmi d\u016fkazy pro antihypertenzn\u00ed \u00fa\u010dinek<\/strong> \u2014 jeho del\u0161\u00ed doba \u00fa\u010dinku a dodate\u010dn\u00e1 anti-aldosteronov\u00e1\/anti-fibrotick\u00e1 aktivita jej \u010din\u00ed vhodn\u011bj\u0161\u00edm pro jednodenn\u00ed kontrolu krevn\u00edho tlaku ne\u017e furosemid.<\/p>\n<p><strong>Dal\u0161\u00ed indikace:<\/strong> <strong>Srde\u010dn\u00ed selh\u00e1n\u00ed:<\/strong> 10-20 mg peror\u00e1ln\u011b denn\u011b zpo\u010d\u00e1tku; titrujte na 10-100 mg\/den. Jednodenn\u00ed d\u00e1vkov\u00e1n\u00ed je obvykle dosta\u010duj\u00edc\u00ed. <strong>Cirhotick\u00fd ascites:<\/strong> 5-40 mg\/den v kombinaci se spironolaktonem 100-200 mg\/den. <strong>Otok p\u0159i CKD:<\/strong> jsou pot\u0159eba vy\u0161\u0161\u00ed d\u00e1vky (20-100 mg\/den) s poklesem po\u010dtu nefron\u016f.<\/p>\n<p><strong>Pod\u00e1v\u00e1n\u00ed:<\/strong> jednou denn\u011b (nebo dvakr\u00e1t denn\u011b u vysok\u00fdch d\u00e1vek kli\u010dkov\u00fdch diuretik p\u0159i srde\u010dn\u00edm selh\u00e1n\u00ed), r\u00e1no. Ve\u010dern\u00ed pod\u00e1v\u00e1n\u00ed zp\u016fsobuje nykturii a m\u011blo by b\u00fdt pokud mo\u017eno vynech\u00e1no. U\u017e\u00edvejte ve stejnou denn\u00ed dobu. Potrava v\u00fdznamn\u011b neovliv\u0148uje vst\u0159eb\u00e1v\u00e1n\u00ed \u017e\u00e1dn\u00e9ho z t\u011bchto diuretik.<\/p>\n<p><strong>Monitorovac\u00ed pl\u00e1n:<\/strong><\/p>\n<ul>\n<li><strong>Vstupn\u00ed vy\u0161et\u0159en\u00ed:<\/strong> mo\u010dovina, elektrolyty (zejm\u00e9na drasl\u00edk a sod\u00edk), kreatinin, eGFR, gluk\u00f3za, s\u00e9rov\u00fd ur\u00e1t. Dom\u00e1c\u00ed nebo klinick\u00e9 m\u011b\u0159en\u00ed TK a denn\u00ed v\u00e1ha u pacient\u016f se srde\u010dn\u00edm selh\u00e1n\u00edm.<\/li>\n<li><strong>1-2 t\u00fddny po zah\u00e1jen\u00ed nebo zm\u011bn\u011b d\u00e1vky:<\/strong> opakujte U&amp;E a kreatinin. O\u010dek\u00e1vejte m\u00edrn\u00e9 zm\u011bny elektrolyt\u016f; vy\u0161et\u0159te v\u00fdrazn\u00e9 odchylky.<\/li>\n<li><strong>4-6 t\u00fddn\u016f:<\/strong> Kontrola krevn\u00edho tlaku a kompletn\u00ed metabolick\u00fd panel.<\/li>\n<li><strong>Pr\u016fb\u011b\u017en\u00e9:<\/strong> Ro\u010dn\u00ed vy\u0161et\u0159en\u00ed U&amp;E, ur\u00e1t\u016f, gluk\u00f3zy a lipidov\u00e9ho panelu po stabilizaci. \u010cast\u011bj\u0161\u00ed u CKD, srde\u010dn\u00edho selh\u00e1n\u00ed nebo p\u0159i kombinovan\u00e9 terapii.<\/li>\n<li><strong>P\u0159eru\u0161it l\u00e9\u010dbu nebo sn\u00ed\u017eit d\u00e1vkov\u00e1n\u00ed p\u0159i:<\/strong> sod\u00edk &lt;130 s p\u0159\u00edznaky, drasl\u00edk 5,5, vzestup kreatininu &gt;30 %, nov\u00e1 dna, p\u0159\u00edznaky t\u011b\u017ek\u00e9 dehydratace.<\/li>\n<\/ul>\n<p><strong>Ukon\u010den\u00ed l\u00e9\u010dby:<\/strong> \u017d\u00e1dn\u00fd abstinen\u010dn\u00ed syndrom, ale n\u00e1hl\u00e9 vysazen\u00ed m\u016f\u017ee zp\u016fsobit rebound retenci tekutin u pacient\u016f se srde\u010dn\u00edm selh\u00e1n\u00edm na chronick\u00e9 vysok\u00e9 d\u00e1vce kli\u010dkov\u00fdch diuretik \u2014 pokud mo\u017eno postupn\u011b sni\u017eovat a monitorovat hmotnost.<\/p>\n<ul>\n<li><strong>Biologick\u00e1 dostupnost 80-100 %<\/strong> (furosemid 10-90 %) \u2014 zvl\u00e1\u0161t\u011b u\u017eite\u010dn\u00e9 u pacient\u016f s m\u011bstnav\u00fdm srde\u010dn\u00edm selh\u00e1n\u00edm, st\u0159evn\u00edm ed\u00e9mem nebo nekonzistentn\u00ed odpov\u011bd\u00ed na furosemid.<\/li>\n<li><strong>M\u00edrn\u00fd antagonismus aldosteronu<\/strong> \u2014 \u010d\u00e1ste\u010dn\u00e1 antifibrotick\u00e1 aktivita v myokardu. Klinick\u00fd v\u00fdznam je m\u00edrn\u00fd; pravd\u011bpodobn\u011b p\u0159isp\u00edv\u00e1 k tomu, pro\u010d studie TORIC prok\u00e1zala benefit.<\/li>\n<li><strong>M\u00e9n\u011b hypokalemick\u00fd<\/strong> ne\u017e furosemid p\u0159i ekvivalentn\u00edch natriuretick\u00fdch d\u00e1vk\u00e1ch (souvis\u00ed s \u00fa\u010dinkem antagonisty aldosteronu).<\/li>\n<li><strong>Ekvivalentn\u00ed d\u00e1vkov\u00e1n\u00ed:<\/strong> torasemid 10 mg \u2248 furosemid 40 mg. U\u017eite\u010dn\u00e9 p\u0159i p\u0159echodu pacient\u016f mezi l\u00e9ky.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n<p><strong>\u010cast\u00e9 (&gt;1 %):<\/strong><\/p>\n<ul>\n<li><strong>Hypokal\u00e9mie<\/strong> (m\u00e9n\u011b ne\u017e furosemid)<\/li>\n<li><strong>Hypomagnez\u00e9mie<\/strong><\/li>\n<li><strong>Hyponatr\u00e9mie<\/strong><\/li>\n<li><strong>Preren\u00e1ln\u00ed AKI<\/strong> p\u0159i nadm\u011brn\u00e9 diur\u00e9ze<\/li>\n<li><strong>Ototoxicita<\/strong> (vz\u00e1cn\u00e9; m\u00e9n\u011b ne\u017e furosemid na jednotku natriur\u00e9zy)<\/li>\n<li><strong>Hyperurik\u00e9mie<\/strong><\/li>\n<li><strong>M\u00edrn\u00e1 hyperglyk\u00e9mie<\/strong><\/li>\n<li><strong>Postur\u00e1ln\u00ed hypotenze<\/strong><\/li>\n<li><strong>Z\u00e1vrat\u011b, bolesti hlavy<\/strong><\/li>\n<\/ul>\n<p><strong>Nep\u0159\u00edli\u0161 \u010dast\u00e9, ale klinicky v\u00fdznamn\u00e9:<\/strong><\/p>\n<ul>\n<li><strong>T\u011b\u017ek\u00e1 hyponatr\u00e9mie<\/strong> \u2014 zejm\u00e9na u star\u0161\u00edch osob na n\u00edzkosoln\u00fdch diet\u00e1ch, p\u0159i stavech n\u00e1chyln\u00fdch k SIADH nebo v kombinaci se SSRI. M\u016f\u017ee se projevit zmatenost\u00ed, p\u00e1dy nebo z\u00e1chvaty.<\/li>\n<li><strong>Pankreatitida<\/strong> \u2014 vz\u00e1cn\u00fd t\u0159\u00eddn\u00ed \u00fa\u010dinek thiazid\u016f\/smy\u010dkov\u00fdch diuretik; okam\u017eit\u011b vysadit p\u0159i bolesti v nadb\u0159i\u0161ku se vzestupem lip\u00e1zy<\/li>\n<li><strong>Trombocytopenie, leukopenie, agranulocyt\u00f3za<\/strong> \u2014 vz\u00e1cn\u00e9 hypersenzitivn\u00ed reakce (\u010dast\u011bj\u0161\u00ed u thiazid\u016f ne\u017e u smy\u010dkov\u00fdch diuretik)<\/li>\n<li><strong>Akutn\u00ed myopie a uzav\u0159en\u00fd \u00fahel glaukomu<\/strong> \u2014 vz\u00e1cn\u00e1 reakce sulfonamidov\u00e9 t\u0159\u00eddy b\u011bhem hodin a\u017e dn\u016f od za\u010d\u00e1tku pod\u00e1v\u00e1n\u00ed; okam\u017eit\u011b vysadit p\u0159i n\u00e1hl\u00e9 bolesti oka nebo zm\u011bn\u011b vid\u011bn\u00ed<\/li>\n<li><strong>Stevens-Johnson\u016fv syndrom \/ toxick\u00e1 epiderm\u00e1ln\u00ed nekrol\u00fdza<\/strong> \u2014 extr\u00e9mn\u011b vz\u00e1cn\u00e9, ale popsan\u00e9<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kontraindikace<\/h2>\n<ul>\n<li>Anurie<\/li>\n<li>P\u0159ecitliv\u011blost na sulfonamidy<\/li>\n<li>T\u011b\u017ek\u00e9 jatern\u00ed selh\u00e1n\u00ed s jatern\u00edm k\u00f3matem<\/li>\n<li>T\u011b\u017ek\u00e1 hyponatr\u00e9mie nebo hypokal\u00e9mie v\u00fdchoz\u00ed<\/li>\n<li>T\u011b\u017ek\u00e1 dehydratace a preren\u00e1ln\u00ed azot\u00e9mie<\/li>\n<\/ul>\n<p><strong>T\u011bhotenstv\u00ed:<\/strong> vyh\u00fdbat se rutinn\u00edmu pou\u017eit\u00ed p\u0159i hypertenzi; pou\u017e\u00edvat pouze pro jasn\u00e9 indikace (plicn\u00ed ed\u00e9m, rezistentn\u00ed srde\u010dn\u00ed selh\u00e1n\u00ed) pod odborn\u00fdm dohledem. Kli\u010dkov\u00e1 diuretika proch\u00e1zej\u00ed placentou a mohou sn\u00ed\u017eit produkci mo\u010di plodu.<\/p>\n<p><strong>Kojen\u00ed:<\/strong> obecn\u011b p\u0159ijateln\u00e9 v n\u00edzk\u00fdch d\u00e1vk\u00e1ch; vysok\u00e9 d\u00e1vky mohou potla\u010dit laktaci (zejm\u00e9na thiazidy). Preferuj\u00ed se alternativn\u00ed antihypertenziva (propranolol, nifedipin), pokud je to mo\u017en\u00e9.<\/p>\n<h2 class=\"wp-block-heading\">Interakce s l\u00e9\u010divy<\/h2>\n<ul>\n<li><strong>Lithium \u2014 KRITICK\u00c1 INTERAKCE.<\/strong> Thiazidov\u00e1 a kli\u010dkov\u00e1 diuretika sni\u017euj\u00ed ren\u00e1ln\u00ed clearance lithia a mohou vyvolat lithiovou toxicitu. Pokud je to mo\u017en\u00e9, kombinaci se vyhn\u011bte; pokud je to nevyhnuteln\u00e9, monitorujte hladiny lithia t\u00fddn\u011b po prvn\u00ed m\u011bs\u00edc a sni\u017ete d\u00e1vku lithia o 25-50 %.<\/li>\n<li><strong>NSAID<\/strong> \u2014 sni\u017euj\u00ed diuretick\u00fd \u00fa\u010dinek (blok\u00e1dou prostaglandin\u016f) a v\u00fdrazn\u011b zvy\u0161uj\u00ed riziko akutn\u00edho po\u0161kozen\u00ed ledvin (AKI) v kombinaci s ACEi\/ARB (tzv. \u201ctriple whammy\u201d). P\u0159i chronick\u00e9 bolesti up\u0159ednost\u0148ujte paracetamol.<\/li>\n<li><strong>ACE inhibitory a ARB<\/strong> \u2014 tato kombinace je standardn\u00ed a prosp\u011b\u0161n\u00e1 u hypertenze; p\u0159id\u00e1n\u00ed ACEi\/ARB blokuje kompenza\u010dn\u00ed aktivaci RAAS a zesiluje diuretick\u00fd \u00fa\u010dinek. Monitorujte hladinu drasl\u00edku a kreatininu.<\/li>\n<li><strong>Drasl\u00edkov\u00e9 dopl\u0148ky a \u0161et\u0159\u00edc\u00ed diuretika<\/strong> \u2014 \u010dasto jsou pot\u0159eba k vyrovn\u00e1n\u00ed hypokal\u00e9mie vyvolan\u00e9 kli\u010dkov\u00fdmi\/thiazidov\u00fdmi diuretiky. Monitorujte hladinu drasl\u00edku; vyhn\u011bte se nadm\u011brn\u00e9 korekci.<\/li>\n<li><strong>Digoxin<\/strong> \u2014 hypokal\u00e9mie zesiluje toxicitu digoxinu (kli\u010dkov\u00e1 a thiazidov\u00e1 diuretika); spironolakton p\u0159\u00edmo sni\u017euje clearance digoxinu. Monitorujte hladiny digoxinu a drasl\u00edku p\u0159i zah\u00e1jen\u00ed nebo zm\u011bn\u011b diuretick\u00e9 l\u00e9\u010dby.<\/li>\n<li><strong>Peror\u00e1ln\u00ed kortikosteroidy, amfotericin B, stimula\u010dn\u00ed laxativa<\/strong> \u2014 aditivn\u00ed hypokal\u00e9mie (kli\u010dkov\u00e1\/thiazidov\u00e1 diuretika) nebo maskovan\u00e1 pot\u0159eba drasl\u00edku (spironolakton).<\/li>\n<li><strong>Peror\u00e1ln\u00ed antidiabetika, inzulin<\/strong> \u2014 thiazidy a (m\u00e9n\u011b) kli\u010dkov\u00e1 diuretika zhor\u0161uj\u00ed gluk\u00f3zovou toleranci; m\u016f\u017ee b\u00fdt nutn\u00e1 \u00faprava d\u00e1vkov\u00e1n\u00ed.<\/li>\n<li><strong>Cholestyramin \/ colestipol<\/strong> \u2014 sni\u017euj\u00ed absorpci thiazid\u016f a kli\u010dkov\u00fdch diuretik o 40\u201385%. D\u00e1vkov\u00e1n\u00ed odd\u011blte 4hodinov\u00fdm intervalem.<\/li>\n<li><strong>Aminoglykosidov\u00e1 antibiotika (gentamicin, amikacin)<\/strong> \u2014 aditivn\u00ed ototoxicita. Vyvarujte se sou\u010dasn\u00e9ho pod\u00e1v\u00e1n\u00ed p\u0159i vysok\u00fdch intraven\u00f3zn\u00edch d\u00e1vk\u00e1ch.<\/li>\n<li><strong>Alkohol<\/strong> \u2014 aditivn\u00ed ortostatick\u00e1 hypotenze.<\/li>\n<\/ul>\n<h2 class=\"wp-block-heading\">Kam se Dytor \u0159ad\u00ed v t\u0159\u00edd\u011b diuretik<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:14px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">T\u0159\u00edda<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Z\u00e1stupci<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Typick\u00e9 pou\u017eit\u00ed<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Thiazid<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/cs\/aquazide\/\">HCTZ<\/a>, chlortalidon<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Prvn\u00ed volba u hypertenze, ledvinov\u00e9 kameny, nefrogenn\u00ed diabetes insipidus<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Thiazid\u016fm podobn\u00e9<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/cs\/natrilix-sr\/\">Indapamid<\/a>, metolazon<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Hypertenze (u star\u0161\u00edch pacient\u016f, d\u016fkazy z HYVET), sekven\u010dn\u00ed blok\u00e1da nefronu<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Kli\u010dkov\u00e1 (kr\u00e1tkodob\u00e1)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/cs\/lasix\/\">Furosemid<\/a>, bumetanide<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Akutn\u00ed plicn\u00ed ed\u00e9m, m\u011bstnav\u00e9 srde\u010dn\u00ed selh\u00e1n\u00ed, ascites, hyperkalc\u00e9mie<\/td>\n<\/tr>\n<tr style=\"background:#fff3cd;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Akutn\u00ed plicn\u00ed ed\u00e9m, CHF, ascites, hyperkalc\u00e9mie<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/cs\/dytor\/\">Kli\u010dkov\u00e1 diuretika (dlouhodob\u00e1)<\/a><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Chronick\u00e9 CHF, HTN (jen kli\u010dkov\u00e1 diuretika s d\u016fkazy HTN), ed\u00e9m p\u0159i CKD<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Chronick\u00e9 CHF, hypertenze (pouze kli\u010dkov\u00e1 diuretika s prok\u00e1zan\u00fdm \u00fa\u010dinkem p\u0159i hypertenzi), ed\u00e9m p\u0159i CKD<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><a href=\"https:\/\/medsbase.com\/cs\/aldactone\/\">Spironolakton<\/a>, Antagonist\u00e9 aldosteronu<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">HF-REF (RALES), resistant HTN (PATHWAY-2), Conn\u2019s, cirrhotic ascites<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">eplerenon<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">HF-REF (RALES), rezistentn\u00ed hypertenze (PATHWAY-2), Conn\u016fv syndrom, cirhotick\u00fd ascites<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Prevence hypokal\u00e9mie p\u0159i p\u0159id\u00e1n\u00ed ke kli\u010dkov\u00e9mu\/thiazidov\u00e9mu diuretiku<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Amilorid, triamteren (obvykle v kombinac\u00edch)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Prevence hypokal\u00e9mie p\u0159i p\u0159id\u00e1n\u00ed ke kli\u010dkov\u00fdm\/thiazidov\u00fdm diuretik\u016fm<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">v\u00fd\u0161kov\u00e1 nemoc, glaukom, metabolick\u00e1 alkal\u00f3za<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2 class=\"wp-block-heading\">Skladov\u00e1n\u00ed<\/h2>\n<p>Skladujte Dytor p\u0159i teplot\u011b ni\u017e\u0161\u00ed ne\u017e 25\u00b0C v p\u016fvodn\u00edm blistru. Uchov\u00e1vejte mimo dosah d\u011bt\u00ed.<\/p>\n<h2 id=\"faqs\">\u010casto kladen\u00e9 dotazy<\/h2>\n<h3 class=\"wp-block-heading\">Kdy m\u00e1m u\u017e\u00edvat Dytor \u2014 r\u00e1no nebo ve\u010der?<\/h3>\n<p><strong>R\u00e1no<\/strong> v t\u00e9m\u011b\u0159 v\u0161ech p\u0159\u00edpadech. Diuretick\u00fd \u00fa\u010dinek zp\u016fsobuje zv\u00fd\u0161enou produkci mo\u010di po dobu 2-4 hodin po pod\u00e1n\u00ed. Ve\u010dern\u00ed d\u00e1vkov\u00e1n\u00ed zp\u016fsobuje nokturii a naru\u0161uje sp\u00e1nek. Pacienti u\u017e\u00edvaj\u00edc\u00ed kli\u010dkov\u00e1 diuretika dvakr\u00e1t denn\u011b obvykle d\u00e1vkuj\u00ed p\u0159i sn\u00eddani a v \u010dasn\u00e9m odpoledni (ne p\u0159ed span\u00edm).<\/p>\n<h3 class=\"wp-block-heading\">Je Dytor l\u00e9kem prvn\u00ed volby na vysok\u00fd krevn\u00ed tlak?<\/h3>\n<p><strong>Ne.<\/strong> Kli\u010dkov\u00e1 diuretika jsou <strong>nejsou l\u00e9ky prvn\u00ed volby na hypertenzi<\/strong> \u2014 jejich \u00fa\u010dinek je p\u0159\u00edli\u0161 kr\u00e1tkodob\u00fd a zp\u016fsobuje kol\u00eds\u00e1n\u00ed krevn\u00edho tlaku. Kli\u010dkov\u00e1 diuretika se p\u0159i hypertenzi pou\u017e\u00edvaj\u00ed pouze ve specifick\u00fdch situac\u00edch: p\u0159i sou\u010dasn\u00e9m otoku zp\u016fsoben\u00e9m srde\u010dn\u00edm selh\u00e1n\u00edm, pokro\u010dil\u00e9m chronick\u00e9m onemocn\u011bn\u00ed ledvin (eGFR &lt;30), kde thiazidy selh\u00e1vaj\u00ed, nebo u rezistentn\u00ed hypertenze jako dopl\u0148kov\u00e1 l\u00e9\u010dba. U standardn\u00ed hypertenze zvolte rad\u011bji thiazid, ARB, ACE inhibitor nebo blok\u00e1tor kalciov\u00fdch kan\u00e1l\u016f.<\/p>\n<h3 class=\"wp-block-heading\">Ovlivn\u00ed Dytor hladinu drasl\u00edku?<\/h3>\n<p>Ano \u2014 Dytor <strong>sni\u017euje<\/strong> drasl\u00edk zv\u00fd\u0161en\u00edm jeho vylu\u010dov\u00e1n\u00ed v dist\u00e1ln\u00edm tubulu. Monitorujte na za\u010d\u00e1tku, po 1-2 t\u00fddnech a periodicky. Riziko hypokal\u00e9mie je <strong>minimalizov\u00e1no kombinac\u00ed<\/strong> Dytor s ARB nebo ACE inhibitorem \u2014 co\u017e je standardn\u00ed kombinace p\u0159i hypertenzi. Pokud hladina drasl\u00edku klesne pod 3,5 p\u0159i samostatn\u00e9m u\u017e\u00edv\u00e1n\u00ed diuretika, p\u0159idejte dopln\u011bk drasl\u00edku, stravu bohatou na drasl\u00edk nebo malou d\u00e1vku \u0161et\u0159\u00edc\u00edho drasl\u00edk (spironolakton, eplerenon nebo <a href=\"https:\/\/medsbase.com\/cs\/amifru\/\">kombinaci obsahuj\u00edc\u00ed amilorid<\/a>).<\/p>\n<h3 class=\"wp-block-heading\">M\u00e1m dnu \u2014 mohu u\u017e\u00edvat Dytor?<\/h3>\n<p>S opatrnost\u00ed. Thiazidy a (m\u00e9n\u011b) kli\u010dkov\u00e1 diuretika zvy\u0161uj\u00ed s\u00e9rovou hladinu kyseliny mo\u010dov\u00e9 konkurenc\u00ed o vylu\u010dov\u00e1n\u00ed v proxim\u00e1ln\u00edm tubulu. U pacient\u016f n\u00e1chyln\u00fdch k dn\u011b: preferujte kombinace s losartanem (<a href=\"https:\/\/medsbase.com\/cs\/cosart-h\/\">Cosart H<\/a>, <a href=\"https:\/\/medsbase.com\/cs\/cozartan-h\/\">Cozartan H<\/a>) jeho\u017e slo\u017eka losartan je v\u00fdjime\u010dn\u011b urikosurick\u00e1 a vyrovn\u00e1v\u00e1 vzestup ur\u00e1t\u016f zp\u016fsoben\u00fd thiazidy. Pokud je Dytor ji\u017e u\u017e\u00edv\u00e1n a dojde k vzplanut\u00ed dny, p\u0159idejte nebo pokra\u010dujte v terapii sni\u017euj\u00edc\u00ed hladinu ur\u00e1t\u016f (alopurinol) sp\u00ed\u0161e ne\u017e \u00fapln\u00e9m vysazen\u00ed Dytoru.<\/p>\n<h3 class=\"wp-block-heading\">M\u00e1m diabetes \u2014 je Dytor bezpe\u010dn\u00fd?<\/h3>\n<p>V\u011bt\u0161inou ano, ale m\u011bjte na pam\u011bti, \u017ee thiazidy a (v men\u0161\u00ed m\u00ed\u0159e) kli\u010dkov\u00e1 diuretika <strong>m\u00edrn\u011b zhor\u0161uj\u00ed gluk\u00f3zovou toleranci<\/strong> (pr\u016fm\u011brn\u00fd n\u00e1r\u016fst glyk\u00e9mie nala\u010dno o 5-8 mg\/dL, HbA1c o 0,1-0,3%). V\u00fdhoda sn\u00ed\u017een\u00ed TK tento efekt u v\u011bt\u0161iny diabetik\u016f p\u0159eva\u017euje. Pokud chcete metabolicky neutr\u00e1ln\u011bj\u0161\u00ed kombinaci, alternativou je ARB+CCB (<a href=\"https:\/\/medsbase.com\/cs\/olmezest-am\/\">Olmezest AM<\/a>).<\/p>\n<h3 class=\"wp-block-heading\">Mohu u\u017e\u00edvat ibuprofen s Dytorem?<\/h3>\n<p>Ob\u010dasn\u00e9 kr\u00e1tkodob\u00e9 u\u017e\u00edv\u00e1n\u00ed je obvykle v po\u0159\u00e1dku. Chronick\u00e9 denn\u00ed u\u017e\u00edv\u00e1n\u00ed NSAID (ibuprofen, diklofenak, naproxen) <strong>sni\u017euje diuretick\u00fd a antihypertenzn\u00ed \u00fa\u010dinek<\/strong> Kombinace Dytoru (blok\u00e1da prostaglandin\u016f) s ACE inhibitorem nebo ARB v\u00fdznamn\u011b zvy\u0161uje riziko akutn\u00edho po\u0161kozen\u00ed ledvin (AKI) \u2013 tzv. \u201ctrojit\u00fd \u00fader\u201d. P\u0159i chronick\u00e9 bolesti up\u0159ednost\u0148ujte paracetamol.<\/p>\n<h3 class=\"wp-block-heading\">Budu v noci v\u00edce mo\u010dit?<\/h3>\n<p>Obvykle ne, pokud u\u017e\u00edv\u00e1te Dytor r\u00e1no. Diuretick\u00fd \u00fa\u010dinek vrchol\u00ed 2-4 hodiny po pod\u00e1n\u00ed a ve\u010der je ji\u017e v\u011bt\u0161inou vyvanul\u00fd. Nokturie je \u010dastou pot\u00ed\u017e\u00ed p\u0159i p\u0159echodu na ve\u010dern\u00ed d\u00e1vkov\u00e1n\u00ed; n\u00e1vrat k rann\u00edmu d\u00e1vkov\u00e1n\u00ed obvykle probl\u00e9m vy\u0159e\u0161\u00ed b\u011bhem 1-3 dn\u016f.<\/p>\n<h3 class=\"wp-block-heading\">Mohu u\u017e\u00edvat Dytor v t\u011bhotenstv\u00ed?<\/h3>\n<p>Rutinn\u011b se vyh\u00fdb\u00e1. Kli\u010dkov\u00e1 diuretika prostupuj\u00ed placentou a mohou ovlivnit plod. P\u0159i hypertenzi v t\u011bhotenstv\u00ed p\u0159ejd\u011bte na <a href=\"https:\/\/medsbase.com\/cs\/labebet\/\">labetalol<\/a>, methyldopu nebo nifedipin. Diuretika se v t\u011bhotenstv\u00ed pou\u017e\u00edvaj\u00ed pouze pro specifick\u00e9 indikace (plicn\u00ed ed\u00e9m, rezistentn\u00ed srde\u010dn\u00ed selh\u00e1n\u00ed) pod dohledem specialisty.<\/p>\n<h3 class=\"wp-block-heading\">Co kdy\u017e vynech\u00e1m d\u00e1vku?<\/h3>\n<p>U\u017eijte ho, jakmile si vzpomenete, pokud ji\u017e nen\u00ed bl\u00edzko \u010das dal\u0161\u00ed d\u00e1vky \u2014 v tom p\u0159\u00edpad\u011b vynechejte zapomenutou d\u00e1vku. Nezdvojujte d\u00e1vku. Jedna vynechan\u00e1 d\u00e1vka v\u00fdznamn\u011b neovlivn\u00ed dlouhodobou kontrolu krevn\u00edho tlaku ani tekutin.<\/p>\n<h3 class=\"wp-block-heading\">Kde lze koupit Dytor online?<\/h3>\n<p>Dytor (5\/10\/20 mg torasemidu, 30-180 tablet) m\u016f\u017eete zakoupit na MedsBase s diskr\u00e9tn\u00edm balen\u00edm a celosv\u011btovou dopravou.<\/p>\n<h2 class=\"wp-block-heading\">Souvisej\u00edc\u00ed antihypertenziva a diuretika na MedsBase<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/amifru\/\">Amifru \u2014 Furosemid + Amilorid (kli\u010dkov\u00e9 + \u0161et\u0159\u00edc\u00ed drasl\u00edk)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/cosart-h\/\">Cosart H \u2014 Losartan + HCTZ fixn\u00ed kombinace<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/losar\/\">Losar \u2014 Losartan (ARB v kombinaci s diuretiky)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/natrilix-sr\/\">Natrilix SR \u2014 Indapamid 1.5 mg SR (thiazidov\u00e9ho typu)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/ramcor\/\">Ramcor \u2014 Ramipril (ACE inhibitor jako partner pro diuretikum)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/telmaheal\/\">Telmaheal \u2014 Telmisartan (ARB partner pro diuretikum)<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/high-blood-pressure-medication\/\"><strong>Prohl\u00e9dnout v\u0161echny l\u00e9ky na vysok\u00fd krevn\u00ed tlak<\/strong><\/a><\/li>\n<\/ul>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:16px 20px;margin:24px 0;border-radius:4px;\"><strong>\u2695 L\u00e9ka\u0159sk\u00e9 upozorn\u011bn\u00ed.<\/strong> Tato str\u00e1nka slou\u017e\u00ed pouze pro informa\u010dn\u00ed \u00fa\u010dely a nenahrazuje l\u00e9ka\u0159skou p\u00e9\u010di kvalifikovan\u00e9ho zdravotnick\u00e9ho pracovn\u00edka. Hypertenze, srde\u010dn\u00ed selh\u00e1n\u00ed a arytmie vy\u017eaduj\u00ed diagn\u00f3zu, monitorov\u00e1n\u00ed a individu\u00e1ln\u00ed d\u00e1vkov\u00e1n\u00ed l\u00e9ka\u0159em \u2014 v\u017edy u\u017e\u00edvejte betablok\u00e1tory pod l\u00e9ka\u0159sk\u00fdm dohledem.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Souvisej\u00edc\u00ed alternativy<\/h3>\n<p>Dal\u0161\u00ed produkty v <strong>Chronick\u00e1 onemocn\u011bn\u00ed<\/strong> kter\u00e9 z\u00e1kazn\u00edci tak\u00e9 prohl\u00ed\u017eej\u00ed:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/cs\/voritrol\/\">Voritrol<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/glynase-mf\/\">Glynase-MF<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/arkamin-h\/\">Arkamin-H<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/fluvoxin\/\">Fluvoxin<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/cs\/hydrosar\/\">Hydrosar<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Dytor jsou torasemidov\u00e9 tablety 5\/10\/20 mg od spole\u010dnosti Cipla \u2014 dlouhodob\u011b p\u016fsob\u00edc\u00ed kli\u010dkov\u00e9 diuretikum s 80-100% p\u0159edv\u00eddatelnou biologickou dostupnost\u00ed (oproti furosemidu 10-90%). Preferov\u00e1no u pacient\u016f se st\u0159evn\u00edm ed\u00e9mem, nepravidelnou odpov\u011bd\u00ed na furosemid nebo pot\u0159ebou jednodenn\u00edho pokryt\u00ed kli\u010dkov\u00fdm diuretikem. M\u00edrn\u00e1 antagonizace aldosteronu sni\u017euje riziko hypokal\u00e9mie. Jedin\u00e9 kli\u010dkov\u00e9 diuretikum s rozumnou evidenci\u00ed pro hypertenzi. TRANSFORM-HF 2023 \u2014 stejn\u00e1 mortalita jako furosemid u srde\u010dn\u00edho selh\u00e1n\u00ed.<\/p>","protected":false},"featured_media":0,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[4941,4942],"class_list":{"0":"post-60882","1":"product","2":"type-product","3":"status-publish","5":"product_cat-category-overview","6":"product_cat-chronic-conditions","7":"product_cat-heart-blood-pressure","8":"product_cat-high-blood-pressure-medication","9":"product_tag-dytor","10":"product_tag-torasemide","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/60882","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=60882"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=60882"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=60882"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=60882"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=60882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}